Stay updated with breaking news from Simon Travis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For patients with chronic pouchitis after undergoing restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis, treatment with vedolizumab is more effective than placebo for inducing remission.
−The Phase 4 EARNEST Study Met Its Primary Efficacy Endpoint of Remission of Chronic or Recurrent Pouchitis at Week 14, with 31% of Participants Receiving Vedolizumab Achieving Remission versus... | March 30, 2023
Biologic effective for common complication of ileal pouch-anal anastomosis in ulcerative colitis
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the CONFIDE Study (Communicating Needs and Features of IBD Experiences) that...
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the CONFIDE Study (Communicating Needs and Features of IBD Experiences) that...